These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 24175804)

  • 21. The prognostic value of lymph node ratio in node-positive breast cancer: a Dutch nationwide population-based study.
    Dings PJ; Elferink MA; Strobbe LJ; de Wilt JH
    Ann Surg Oncol; 2013 Aug; 20(8):2607-14. PubMed ID: 23536053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can lymph node ratio replace pn categories in the tumor-node-metastasis classification system for esophageal cancer?
    Tan Z; Ma G; Yang H; Zhang L; Rong T; Lin P
    J Thorac Oncol; 2014 Aug; 9(8):1214-21. PubMed ID: 25157776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic value of lymph node ratio in survival of non-metastatic breast carcinoma patients.
    Singh D; Mandal A
    Breast Cancer Res Treat; 2020 Dec; 184(3):839-848. PubMed ID: 32852709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and validation of a nomogram for predicting survival on the base of modified lymph node ratio in breast cancer patients.
    Wen J; Yang Y; Liu P; Ye F; Tang H; Huang X; Zhong S; Xie X
    Breast; 2017 Jun; 33():14-22. PubMed ID: 28259045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymph node ratio as an alternative to pN staging for predicting prognosis after neoadjuvant chemotherapy in breast cancer.
    Cho DH; Bae SY; You JY; Kim HK; Chang YW; Choi YJ; Woo SU; Son GS; Lee JB; Bae JW; Jung SP
    Kaohsiung J Med Sci; 2018 Jun; 34(6):341-347. PubMed ID: 29747778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
    Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
    Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can lymph node ratio take the place of pN categories in the UICC/AJCC TNM classification system for colorectal cancer?
    Tong LL; Gao P; Wang ZN; Song YX; Xu YY; Sun Z; Xing CZ; Wang X; Xu HM
    Ann Surg Oncol; 2011 Sep; 18(9):2453-60. PubMed ID: 21455596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between Lymph Node Ratio and Disease Specific Survival in Breast Cancer Patients with One or Two Positive Lymph Nodes Stratified by Different Local Treatment Modalities.
    Hong R; Dai Z; Zhu W; Xu B
    PLoS One; 2015; 10(10):e0138908. PubMed ID: 26513258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer.
    Sosa JA; Diener-West M; Gusev Y; Choti MA; Lange JR; Dooley WC; Zeiger MA
    Ann Surg Oncol; 1998 Mar; 5(2):140-9. PubMed ID: 9527267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of axillary lymph node metastases in invasive lobular breast carcinoma.
    Deberti M; Goupille C; Arbion F; Vilde A; Body G; Ouldamer L
    J Gynecol Obstet Hum Reprod; 2023 Dec; 52(10):102665. PubMed ID: 37734568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the prognostic value of the metastatic lymph node ratio for gastric cancer.
    Zhang BY; Yuan J; Cui ZS; Li ZW; Li XH; Lu YY
    Am J Surg; 2014 Apr; 207(4):555-65. PubMed ID: 24124661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of lymph node ratio in node-positive breast cancer in Egyptian patients.
    Elkhodary TR; Ebrahim MA; Hatata EE; Niazy NA
    J Egypt Natl Canc Inst; 2014 Mar; 26(1):31-5. PubMed ID: 24565680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive Value of the Number of Harvested Lymph Nodes and Cut-Off for Lymph Node Ratio in the Prognosis of Stage II and III Colorectal Cancer Patients.
    Li Destri G; Barchitta M; Pesce A; Latteri S; Bosco D; Di Cataldo A; Agodi A; Puleo S
    J Invest Surg; 2019 Jan; 32(1):1-7. PubMed ID: 28972442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Value of Lymph Node Ratio in Breast Cancer Patients with Adequate Pathologic Evidence After Neoadjuvant Chemotherapy.
    Ai X; Liao X; Wang M; Hu Y; Li J; Zhang Y; Tang P; Jiang J
    Med Sci Monit; 2020 Apr; 26():e922420. PubMed ID: 32348295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ratio of metastatic lymph nodes is more important for rectal cancer patients treated with preoperative chemoradiotherapy.
    Park IJ; Yu CS; Lim SB; Yoon YS; Kim CW; Kim TW; Kim JH; Kim JC
    World J Gastroenterol; 2015 Mar; 21(11):3274-81. PubMed ID: 25805934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of number of removed lymph nodes, number of involved lymph nodes, and lymph node ratio in 7502 breast cancer patients enrolled onto trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG).
    Tausch C; Taucher S; Dubsky P; Seifert M; Reitsamer R; Kwasny W; Jakesz R; Fitzal F; Filipcic L; Fridrik M; Greil R; Gnant M
    Ann Surg Oncol; 2012 Jun; 19(6):1808-17. PubMed ID: 22207051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Better predictive value of axillary lymph node (ALN) status after systemic therapy for operable HER2-overexpressing breast cancer: A single-institution retrospective study.
    Zhang Y; Mo M; Li JW; Zhou Y; Wu J; Yu KD; Shen ZZ; Shao ZM; Liu GY
    Eur J Surg Oncol; 2016 Aug; 42(8):1146-52. PubMed ID: 27365197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High Ki67 predicts unfavourable outcomes in early breast cancer patients with a clinically clear axilla who do not receive axillary dissection or axillary radiotherapy.
    Zurrida S; Bagnardi V; Curigliano G; Mastropasqua MG; Orecchia R; Disalvatore D; Greco M; Cataliotti L; D'Aiuto G; Talakhadze N; Goldhirsch A; Viale G
    Eur J Cancer; 2013 Oct; 49(15):3083-92. PubMed ID: 23777741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Axillary lymph node dissection versus no dissection in patients with T1N0 breast cancer: a randomized clinical trial (INT09/98).
    Agresti R; Martelli G; Sandri M; Tagliabue E; Carcangiu ML; Maugeri I; Pellitteri C; Ferraris C; Capri G; Moliterni A; Bianchi G; Mariani G; Trecate G; Lozza L; Langer M; Rampa M; Gennaro M; Greco M; Menard S; Pierotti MA
    Cancer; 2014 Mar; 120(6):885-93. PubMed ID: 24323615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.